Annual D&A
$2.17 M
-$242.00 K-10.02%
December 31, 2023
Summary
- As of February 12, 2025, FULC annual depreciation & amortization is $2.17 million, with the most recent change of -$242.00 thousand (-10.02%) on December 31, 2023.
- During the last 3 years, FULC annual D&A has fallen by -$207.00 thousand (-8.70%).
- FULC annual D&A is now -13.64% below its all-time high of $2.52 million, reached on December 31, 2021.
Performance
FULC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$369.00 K
-$7000.00-1.86%
September 30, 2024
Summary
- As of February 12, 2025, FULC quarterly depreciation & amortization is $369.00 thousand, with the most recent change of -$7000.00 (-1.86%) on September 30, 2024.
- Over the past year, FULC quarterly D&A has dropped by -$139.00 thousand (-27.36%).
- FULC quarterly D&A is now -49.66% below its all-time high of $733.00 thousand, reached on December 31, 2020.
Performance
FULC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.73 M
-$162.00 K-8.55%
September 30, 2024
Summary
- As of February 12, 2025, FULC TTM depreciation & amortization is $1.73 million, with the most recent change of -$162.00 thousand (-8.55%) on September 30, 2024.
- Over the past year, FULC TTM D&A has dropped by -$440.00 thousand (-20.26%).
- FULC TTM D&A is now -34.07% below its all-time high of $2.63 million, reached on September 30, 2021.
Performance
FULC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
FULC Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.0% | -27.4% | -20.3% |
| 3 y3 years | -8.7% | -27.4% | -20.3% |
| 5 y5 years | +61.5% | -27.4% | -20.3% |
FULC Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.6% | at low | -45.4% | at low | -31.1% | at low |
| 5 y | 5-year | -13.6% | +5.8% | -49.7% | at low | -34.1% | at low |
| alltime | all time | -13.6% | +203.8% | -49.7% | +112.1% | -34.1% | +895.4% |
Fulcrum Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $369.00 K(-1.9%) | $1.73 M(-8.6%) |
| Jun 2024 | - | $376.00 K(-21.5%) | $1.89 M(-9.2%) |
| Mar 2024 | - | $479.00 K(-5.7%) | $2.08 M(-4.0%) |
| Dec 2023 | $2.17 M(-10.0%) | $508.00 K(-4.3%) | $2.17 M(-3.7%) |
| Sep 2023 | - | $531.00 K(-6.3%) | $2.25 M(-3.4%) |
| Jun 2023 | - | $567.00 K(+0.2%) | $2.33 M(-4.5%) |
| Mar 2023 | - | $566.00 K(-4.2%) | $2.44 M(+1.2%) |
| Dec 2022 | $2.41 M(-4.0%) | $591.00 K(-3.3%) | $2.41 M(-1.2%) |
| Sep 2022 | - | $611.00 K(-9.6%) | $2.44 M(-0.3%) |
| Jun 2022 | - | $676.00 K(+26.1%) | $2.45 M(+0.2%) |
| Mar 2022 | - | $536.00 K(-13.7%) | $2.45 M(-2.7%) |
| Dec 2021 | $2.52 M | $621.00 K(+0.3%) | $2.52 M(-4.3%) |
| Sep 2021 | - | $619.00 K(-7.9%) | $2.63 M(+2.5%) |
| Jun 2021 | - | $672.00 K(+11.4%) | $2.56 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $603.00 K(-17.7%) | $2.44 M(+2.7%) |
| Dec 2020 | $2.38 M(+15.9%) | $733.00 K(+32.3%) | $2.38 M(+9.9%) |
| Sep 2020 | - | $554.00 K(+0.2%) | $2.17 M(+1.8%) |
| Jun 2020 | - | $553.00 K(+2.6%) | $2.13 M(+1.9%) |
| Mar 2020 | - | $539.00 K(+3.9%) | $2.09 M(+1.7%) |
| Dec 2019 | $2.05 M(+52.6%) | $519.00 K(+0.6%) | $2.05 M(+0.5%) |
| Sep 2019 | - | $516.00 K(+0.4%) | $2.04 M(+2.9%) |
| Jun 2019 | - | $514.00 K(+2.0%) | $1.99 M(+18.6%) |
| Mar 2019 | - | $504.00 K(-1.0%) | $1.68 M(+24.5%) |
| Dec 2018 | $1.34 M(+88.1%) | $509.00 K(+10.9%) | $1.34 M(+60.9%) |
| Sep 2018 | - | $459.00 K(+126.1%) | $836.00 K(+121.8%) |
| Jun 2018 | - | $203.00 K(+16.7%) | $377.00 K(+116.7%) |
| Mar 2018 | - | $174.00 K | $174.00 K |
| Dec 2017 | $715.00 K | - | - |
FAQ
- What is Fulcrum Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual D&A year-on-year change?
- What is Fulcrum Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly D&A year-on-year change?
- What is Fulcrum Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics TTM D&A year-on-year change?
What is Fulcrum Therapeutics annual depreciation & amortization?
The current annual D&A of FULC is $2.17 M
What is the all time high annual D&A for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual depreciation & amortization is $2.52 M
What is Fulcrum Therapeutics annual D&A year-on-year change?
Over the past year, FULC annual depreciation & amortization has changed by -$242.00 K (-10.02%)
What is Fulcrum Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of FULC is $369.00 K
What is the all time high quarterly D&A for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly depreciation & amortization is $733.00 K
What is Fulcrum Therapeutics quarterly D&A year-on-year change?
Over the past year, FULC quarterly depreciation & amortization has changed by -$139.00 K (-27.36%)
What is Fulcrum Therapeutics TTM depreciation & amortization?
The current TTM D&A of FULC is $1.73 M
What is the all time high TTM D&A for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM depreciation & amortization is $2.63 M
What is Fulcrum Therapeutics TTM D&A year-on-year change?
Over the past year, FULC TTM depreciation & amortization has changed by -$440.00 K (-20.26%)